Low-Density Lipoprotein Size, Pravastatin Treatment, and Coronary Events.

Authors :: Campos, Hannia
Moye, Lemuel A.
Glasser, Stephen P.
Stampfer, Meir J.
Sacks, Frank M.
Source :: JAMA: Journal of the American Medical Association; 9/29/2001, Vol. 286 Issue 12, p1468, 7p, 3 Charts, 1 Graph
Publication Year :: 2001
Abstract: Presents a study to examine whether low-density lipoprotein (LDL) size is an independent predictor of recurrent coronary events in patients with known coronary heart disease (CHD), as opposed to a marker for other lipid abnormalities. Context; Objective; Design and setting; Participants; Main outcome measure; Results; Conclusions.